D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.27% |
| 2 | Healthcare | 11.28% |
| 3 | Consumer Discretionary | 8.99% |
| 4 | Communication Services | 8.03% |
| 5 | Industrials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XENT
1801
DELISTED
Intersect ENT, Inc
XENT
| $3.03M | ﹤0.01% |
93,511
-43,969
| -32% | -$1.32M |
|
|
ARRY
1802
DELISTED
Array Biopharma Inc
ARRY
| $3.03M | ﹤0.01% |
236,436
+71,503
| +43% | +$813K |
|
1803
Valmont Industries
VMI
$9.36B
| $3.02M | ﹤0.01% |
18,208
-39,455
| -68% | -$6.42M |
|
|
STML
1804
DELISTED
Stemline Therapeutics, Inc.
STML
| $3.01M | ﹤0.01% |
192,833
+105,539
| +121% | +$1.41M |
|
|
GRP.U
1805
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $3M | ﹤0.01% |
76,768
+6,100
| +9% | +$241K |
|
|
MTOR
1806
DELISTED
MERITOR, Inc.
MTOR
| $3M | ﹤0.01% |
127,944
+27,439
| +27% | +$689K |
|
1807
CALL
PACCAR
PCAR
$69.5B
| $3M | ﹤0.01% |
63,300
| – | – |
|
1808
PUT
Vertex Pharmaceuticals
VRTX
$123B
| $3M | ﹤0.01% |
20,000
| – | – |
|
1809
Qorvo
QRVO
$8.04B
| $2.99M | ﹤0.01% |
44,929
+32,029
| +248% | +$2.33M |
|
|
BCOV
1810
DELISTED
Brightcove, Inc.
BCOV
| $2.99M | ﹤0.01% |
420,998
+49,048
| +13% | +$355K |
|
1811
PUT
Howard Hughes
HHH
$3.94B
| $2.98M | ﹤0.01% |
23,812
+2,937
| +14% | +$350K |
|
1812
Sonida Senior Living
SNDA
$2.03B
| $2.98M | ﹤0.01% |
14,721
+2,166
| +17% | +$464K |
|
1813
CALL
W.W. Grainger
GWW
$66.4B
| $2.98M | ﹤0.01% |
12,600
-24,000
| -66% | -$4.96M |
|
1814
MKS Inc
MKSI
$19B
| $2.98M | ﹤0.01% |
31,484
-18,543
| -37% | -$1.85M |
|
1815
Alaska Air
ALK
$5.47B
| $2.97M | ﹤0.01% |
40,342
-90,070
| -69% | -$6.4M |
|
|
NTRI
1816
DELISTED
NutriSystem, Inc.
NTRI
| $2.97M | ﹤0.01% |
56,392
+28,830
| +105% | +$1.51M |
|
|
STKL
1817
DELISTED
SunOpta
STKL
| $2.96M | ﹤0.01% |
382,515
+6,503
| +2% | +$54.3K |
|
1818
PUT
Agnico Eagle Mines
AEM
$72B
| $2.96M | ﹤0.01% |
64,100
+38,900
| +154% | +$1.74M |
|
1819
CALL
Becton Dickinson
BDX
$45.3B
| $2.95M | ﹤0.01% |
14,145
+12,710
| +886% | +$2.66M |
|
1820
Honda
HMC
$39.4B
| $2.95M | ﹤0.01% |
86,691
-138,322
| -61% | -$4.47M |
|
1821
Natera
NTRA
$36.7B
| $2.95M | ﹤0.01% |
328,509
+53,944
| +20% | +$583K |
|
1822
Onto Innovation
ONTO
$11.7B
| $2.95M | ﹤0.01% |
118,370
+98,505
| +496% | +$2.62M |
|
1823
Radian Group
RDN
$5.22B
| $2.93M | ﹤0.01% |
142,211
-135,519
| -49% | -$2.79M |
|
|
KTWO
1824
DELISTED
K2M Group Holdings, Inc
KTWO
| $2.92M | ﹤0.01% |
162,318
+65,329
| +67% | +$1.24M |
|
1825
CALL
CME Group
CME
$93.9B
| $2.92M | ﹤0.01% |
+20,000
| New | +$2.85M |
|
Similar funds
D.E. Shaw & Co's Q4 2017 Portfolio in Review
As of Q4 2017, D.E. Shaw & Co held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- D.E. Shaw & Co's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- D.E. Shaw & Co added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- D.E. Shaw & Co's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- D.E. Shaw & Co fully exited Tesla in Q4 2017, selling an estimated $230M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- D.E. Shaw & Co opened 507 new positions and closed 394 in Q4 2017.
- D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.